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In LVHN’s high-risk COPD population, what is the impact of 
depression on healthcare utilization and cost? 
Approximately 17.8% of the US GDP in 2015 was spent on 
healthcare.1 Notably, 5% of the patient population accounts 
for 50% of that healthcare spending.2 There have been many 
initiatives set forth for reducing healthcare cost within many 
healthcare systems. Most healthcare groups focus on targeting 
the “hot-spotters” who are super utilizers;3 however, the 
population that cannot be taken for granted are high-risk patients, 
defined as those who can be predicted to over-utilize in the 
future. Utilization in healthcare was defined as consumption of 
services or supplies, such as office visits, number of prescription 
drugs taken, or number of days hospitalized.4 Within that subset 
of utilizers, about 6.4% of Americans, 15.7 million, have been 
diagnosed with COPD.5 COPD was the fifth leading cause of death 
in the United States in 2015.6 Previous studies have shown the 
link between depression and COPD, suggesting that individuals 
with chronic conditions, such as COPD, are more likely to have 
depression. They have also shown that depressive symptoms 
– including lack of sleep or fluctuating eating habits – have 
contributed to worsening dyspnea, increased COPD exacerbations, 
more frequent ED visits, and hospitalizations. This analysis aims 
to look at the effect depression has on the care and cost of Lehigh 
Valley Health Network’s (LVHN) COPD population. As part of a 
secondary analysis, it will also look at the effect of insurance 
status (e.g., commercial or Medicare on the two cohorts (e.g., 
COPD patients with depression and COPD patients without 
depression).
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Problem Statement
             
Results
 
There is a positive correlation between depression and increased health care utilization for patients with COPD, 
regardless of health insurance provider. Furthermore, Medicare beneficiaries with COPD and depression are at an 
even higher risk for increased utilization. In the future, further investigation of potential countermeasures, such as 
earlier diagnosis (e.g., increased PHQ-9 screening), improved treatment of depression, and adoption of innovative 
techniques  (e.g., telemedicine) should be done to elaborate on ways of decreasing utilization and optimizing quality 
outcomes for the cohort of patients with COPD and depression. 
This project mainly encompasses all three pillars of SELECT. In regards to healthcare, we strived to improve 
utilization outcomes by targeting high-risk COPD patients and looking at the relationship between those who have 
depression compared to those without. As the trend detected showed increased ED visits, hospitalizations and 30-
day readmission rates in those with depression, the next discussion lies in whether these patients are satisfied with 
their quality of care and whether their care aligns with their values. Lastly, I personally grew as a leader through 
my communication skills, in my ability to influence others with data, in my ability to manipulate data on multiple 
software programs, and learn from others who have mastered topics I have not.
Conclusions and Future Work
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Methods
•  A retrospective  quality improvement analysis of two cohorts: 
LVHN’s COPD population with depression (n= 12,802) and 
LVHN’s COPD population without depression (n = 26,868), ages 
ranging from 21-106 for whom three years of data was collected 
(01/01/2014 -11/30/2017). 
•  The two cohorts were further compared by insurance providers 
(i.e., commercial and Medicare). 
•  The data was collected through healthcare intelligence software 
(e.g., Optum One) that pulled from electronic medical records and 
claims 
•  Gained buy-in at meetings with the Senior Medical Director of 
Population Health and Payer Relations, the Executive Director of 
LVPHO, and pulmonology care management leaders
•  This analysis suggested a positive correlation between depression and increased ambulatory 
visits, emergency visits, hospitalizations, and 30-day readmissions in COPD patients, regardless of 
insurance provider. 
•  This was reflected in increased costs for COPD patients with depression compared to those without. 
•  Medicare beneficiaries had increased utilization and cost compared to the commercially insured. 
•  This analysis also demonstrated a difference between the risk adjustment factor (RAF) between 
the COPD cohort without depression (average RAF of 1.012) and the COPD cohort with depression 
(average RAF of 1.552), signifying about a 53% increase. As the COPD severity worsened, the RAF 
score increased. 
Figure 1: Closer look: COPD populations analyzed 
Figure 2: Average Number of COPD-related Visits. This figure 
demonstrates that in the MSSP population, the ambulatory visits, 
emergency visits, and hospitalizations, and 30-day readmissions were 
43%, 115%, 104%, and 143% greater in patients with depression than 
without, respectively. In the commercially insured, the rates of emergency 
visits, hospitalizations, and 30-day readmissions were 22%, 4%, and 
50% greater in patients with depression than without, respectively.
Figure 3: Average Cost for all COPD-Related Visits. In the MSSP 
population, cost for ambulatory visits, ED visits, and hospitalizations were 
36%, 160%, and110% increased in patients with depression compared to 
those without, respectively. Likewise, in the commercial population, cost 
for ambulatory visits, ED visits, and hospitalizations were 105%, 213%, 
and 133% increased in patients with depression compared to those 
without, respectively.
Figure 4: Driver Diagram for reduction of depression within the COPD cohort. The above diagram shows factors that interplay 





To increase the rate
of remission of 
depression in COPD 
patients
Reduce rate of ED visits







Rate of 30-day readmission 
rates
Targeted Ambulatory Visits /Use 
of Telemedicine
SpO2 Home Monitoring 
Heart rate and 
Anxiety/Depression Log
Implementing Depression 
Screening Tools for COPD pts.
Increased use of CBT
Improved pharmacological 
treatment















Average Number of COPD-related Visits 




















Average Cost for all COPD-Related Visits
Average cost for total Ambulatory Visits Average cost for total ED Visits Average cost for total Hospitlizations
Acknowledgements:
Mark Wendling, M.D.,  Nina M. Taggart, MD, MA, MBA, FAAO, Sameera Ahmed, MS, RHIA, CHDA, Michael J Weiss MPH, and The 
Populytics Analytical Team.
Lehigh Valley Health Network, Allentown, PA
Average Number of COPD-Related Visits Average Cost for all COPD-Related Visits
